Glucagon News and Research

RSS
How lipoproteins shape your metabolic health

How lipoproteins shape your metabolic health

Tirzepatide outperforms semaglutide in weight loss for overweight and obese adults

Tirzepatide outperforms semaglutide in weight loss for overweight and obese adults

Combined use of popular diabetes drugs likely to offer additional protection against heart and kidney disease

Combined use of popular diabetes drugs likely to offer additional protection against heart and kidney disease

Semaglutide linked to increased risk of severe eye condition NAION in new study

Semaglutide linked to increased risk of severe eye condition NAION in new study

GLP-1 drugs found to lower cancer risk in diabetes patients

GLP-1 drugs found to lower cancer risk in diabetes patients

Semaglutide and very-low calorie diet combo shows superior results in managing type 2 diabetes

Semaglutide and very-low calorie diet combo shows superior results in managing type 2 diabetes

Study suggests shift work increases risk of premature ejaculation in men

Study suggests shift work increases risk of premature ejaculation in men

New study reveals how GLP-1 receptor agonists enhance preingestive fullness

New study reveals how GLP-1 receptor agonists enhance preingestive fullness

Study reveals exercise and GLP-1 RA combination preserves bone health during weight loss

Study reveals exercise and GLP-1 RA combination preserves bone health during weight loss

Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study

Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study

New drug tirzepatide significantly improves sleep apnea and weight loss

New drug tirzepatide significantly improves sleep apnea and weight loss

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

Semaglutide weight loss results linked to diabetes severity

Semaglutide weight loss results linked to diabetes severity

WHO issues medical product alert on falsified semaglutides

WHO issues medical product alert on falsified semaglutides

Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study

Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study

Safety-focused summary of GLP-1 receptor agonists in diabetes, obesity, and beyond

Safety-focused summary of GLP-1 receptor agonists in diabetes, obesity, and beyond

Study reveals individual differences in fasting-induced ketosis and its health benefits

Study reveals individual differences in fasting-induced ketosis and its health benefits

Wegovy and Ozempic linked to reduced incidence and recurrence of alcohol abuse or dependence, study suggests

Wegovy and Ozempic linked to reduced incidence and recurrence of alcohol abuse or dependence, study suggests

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.